FDA Inspection 1110557 — Triumpharma Bioanalytical Lab
The FDA completed an inspection of Triumpharma Bioanalytical Lab on October 31, 2019 in Amman. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- October 31, 2019
- Fiscal Year
- 2020
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Amman (Jordan)
Additional Details
Clinical BA/BE